Literature DB >> 17404044

Generation of DeltaTAp73 proteins by translation from a putative internal ribosome entry site.

A Emre Sayan1, Jean-Pierre Roperch, Berna S Sayan, Mario Rossi, M J Pinkoski, Richard A Knight, Anne E Willis, Gerry Melino.   

Abstract

p73 belongs to a family of transcription factors, including p53 and p63, that mediate response to DNA damage and cellular stress by inducing DNA repair, cell cycle arrest, and apoptosis. TP73 gene contains two promotors and several splice variants resulting in up to 24 possible permutations of p73 proteins which underlies the complexity of the family and its regulatory mechanisms. p73 variants lacking the N-terminal, denoted as DeltaTAp73, are not transcriptionally competent and they act in a dominant negative fashion over TAp73. DeltaTAp73 isoforms can be generated by alternative promotor usage, giving rise to DeltaNp73, or alternative splicing of exons 2, 3 or 2, and 3 together. Such transcript isoforms potentially produce oncogenic proteins and they were shown to be present in primary tumors and tumor-derived cell lines. We investigated the possibility of additional mechanisms by which p73 protein could be regulated and discovered a putative internal ribosome entry site (IRES) in exon 2. Translation initiation of TAp73 mRNA results in a DeltaNp73-like peptide, thus demonstrating an additional mechanism whereby a DeltaTA p73 protein is produced from a transcript originally generated from the P1 promotor of the p73 gene.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404044     DOI: 10.1196/annals.1397.035

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

Review 1.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

2.  Deregulation of Internal Ribosome Entry Site-Mediated p53 Translation in Cancer Cells with Defective p53 Response to DNA Damage.

Authors:  Marie-Jo Halaby; Benjamin R E Harris; W Keith Miskimins; Margot P Cleary; Da-Qing Yang
Journal:  Mol Cell Biol       Date:  2015-09-21       Impact factor: 4.272

3.  A gene signature-based approach identifies mTOR as a regulator of p73.

Authors:  Jennifer M Rosenbluth; Deborah J Mays; Maria F Pino; Luo Jia Tang; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2008-08-04       Impact factor: 4.272

Review 4.  Regulation of p73 activity by post-translational modifications.

Authors:  F Conforti; A E Sayan; R Sreekumar; B S Sayan
Journal:  Cell Death Dis       Date:  2012-03-15       Impact factor: 8.469

5.  Relative expression of TAp73 and ΔNp73 isoforms.

Authors:  Franco Conforti; Ai Li Yang; Massimiliano Agostini; Alessandro Rufini; Paola Tucci; Maria Victoria Nicklison-Chirou; Francesca Grespi; Tania Velletri; Richard A Knight; Gerry Melino; Berna S Sayan
Journal:  Aging (Albany NY)       Date:  2012-03       Impact factor: 5.682

6.  Translational Control Protein 80 Stimulates IRES-Mediated Translation of p53 mRNA in Response to DNA Damage.

Authors:  Marie-Jo Halaby; Yan Li; Benjamin R Harris; Shuxia Jiang; W Keith Miskimins; Margot P Cleary; Da-Qing Yang
Journal:  Biomed Res Int       Date:  2015-07-26       Impact factor: 3.411

Review 7.  Targeting IRES-Mediated p53 Synthesis for Cancer Diagnosis and Therapeutics.

Authors:  Bai Ji; Benjamin R E Harris; Yahui Liu; Yibin Deng; Sergio A Gradilone; Margot P Cleary; Jianhua Liu; Da-Qing Yang
Journal:  Int J Mol Sci       Date:  2017-01-04       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.